XML 114 R71.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based payments transactions (Tables)
 12 Months Ended
Mar. 31, 2023
Share-Based Payments Transactions [Abstract]  
Disclosure of Movement in the Share-Based Payment Liability The movement in the share-based payment liability during the period is reflected below:
(EUR thousand)For the financial year ended March 31, 2021
Opening balance7,396 
Valuation up to August 27974 
SBP value as of August 278,370 
Expense recognized in the profit and loss upon capital reorganization58,744 
SBP value as of August 2867,114 
Cash settlements upon reorganization(29,333)
Conversion upon reorganization of remaining SBP liability to equity at FV(37,781)
Closing balance— 
Disclosure of Movement in the NC-PECs Liability
The movement in the NC-PECs liability is reflected below:
(EUR thousand)For the financial year ended March 31, 2021
Nominal value including accrued interest on NC-PECs issued at the beginning of the year1,920 
Mark-to-market fair value charge(138)
Accrued interests on NC-PECs79 
Transfer to equity(1,861)
Reclassifications— 
Total value of NC-PECs direct investment— 
Value at the beginning of the year2,971 
Accrued interest120 
Derecognition of residual amount to profit and loss(101)
Transfer to equity(2,990)
Reclassifications— 
Interest bearing obligations towards senior management of Global Blue Group— 
Total value of NC-PECs including accrued interest— 

(Thousand of units)For the financial year ended March 31, 2021
NC-PECs issued at the beginning of the year927 
Issuance of NC-PECs— 
Transfer of NC-PECs to equity(927)
Number of NC-PECs issued— 
Disclosure of Number and Reconciliation of Outstanding Share Options
On October 23, 2020, a total of 8 million share options were granted to employees of the Group with four tranches of options vesting on four respective vesting dates (“SOP 2020”), whereas within each of the four tranches, there are further four tranches of options with four different exercise prices, as below:
Vesting dateTotal
Share options granted (thousands)05/03/202205/09/202205/09/202305/09/2024
US$8.50971 324 647 647 2,589 
US$10.50822 274 548 548 2,192 
US$12.50673 224 448 448 1,793 
US$14.50523 175 349 349 1,396 
Total2,989 997 1,992 1,992 7,970 
The strike price of the existing SOP grants has been adjusted as set forth below, while all the other terms of the SOP 2020 and SOP 2019 remained unaffected.
SOP 2020 MOD - Number of shares (thousand)
Original Option Strike PriceNew Option Strike PriceVesting dateTotal
15/02/202215/08/202215/08/202315/08/2024
US$8.50 US$6.42 335 112 223 223 893 
US$10.50 US$8.42 284 95 189 189 757 
US$12.50 US$10.42 232 77 155 155 619 
US$14.50 US$12.42 180 60 120 120 480 
Total1,031 344 687 687 2,749 
The following table shows the SOPs granted and outstanding at the beginning and end of the reporting periods:
For the financial year ended March 31
202320222021
Average exercise price per share option (USD)Number of options (thousands)Average exercise price per share option (USD)Number of options (thousands)Average exercise price per share option (USD)Number of options (thousands)
As of April 111.42 7,980 11.40 8,457 — — 
Granted during the year— — — — 11.40 8,457 
Forfeited during the year11.50 (28)10.98 (477)— — 
As of March 3111.42 7,952 11.42 7,980 11.40 8,457 
Vested and exercisable of March 3111.42 4,072 11.01 2,925 — — 
Number of shares (million)For the financial year ended March 31, 2023
As of April 1— 
Granted during the year452 
Vested during the year— 
Forfeited during the year— 
As of March 31452 
Weighted average fair value (EUR)0.13 
Weighted average remaining contractual life of options outstanding at the end of the period (years)2.5
Disclosure of Indirect Measurement of Fair Value of Share Options Granted The revised model inputs and fair values at grant date are:
SOP 2019
Vesting date24/6/202223/6/2024
Share price at grant date (USD)10.5910.59
Exercise price (USD)10.5910.59
Expected volatility25.00%25.00%
Risk free interest rate1.91%1.91%
Fair value at grant date (USD)1.591.59

 SOP 2020
Vesting date5/3/20225/9/20225/9/20235/9/2024
Share price at grant date (USD)8.648.648.648.64
Expected volatility21.50%21.50%21.50%21.50%
Risk free interest rate0.50%0.50%0.50%0.50%
Exercise price (USD)8.508.508.508.50
Fair value at grant date (USD)1.541.541.521.49
Exercise price (USD)10.5010.5010.5010.50
Fair value at grant date (USD)0.960.960.960.95
Exercise price (USD)12.5012.5012.5012.50
Fair value at grant date (USD)0.610.610.610.61
Exercise price (USD)14.5014.5014.5014.50
Fair value at grant date (USD)0.390.390.390.39

SOP 2020 MOD
Vesting date5/3/20225/9/20225/9/20235/9/2024
Share price at grant date (USD)8.648.648.648.64
Expected volatility21.50%21.50%21.50%21.50%
Risk free interest rate0.50%0.50%0.50%0.50%
Exercise price (USD)6.426.426.426.42
Fair value at grant date (USD)2.522.502.452.37
Exercise price (USD)8.428.428.428.42
Fair value at grant date (USD)1.571.571.551.52
Exercise price (USD)10.4210.4210.4210.42
Fair value at grant date (USD)0.980.980.970.96
Exercise price (USD)12.4212.4212.4212.42
Fair value at grant date (USD)0.620.620.620.62
Grant date31/10/202231/10/202231/10/2022
Vesting date31/12/202431/12/202531/12/2026
Number of shares (million)226.0113.0113.0
Expected volatility9.7 %9.7 %9.7 %
Discount rate14.3 %14.3 %14.3 %
Fair value per option as of March 31, 2023 (EUR)0.030.120.33
Disclosure of Range of Exercise Prices of Outstanding Share Options
Share options outstanding at the end of the year have the following expiry dates and exercise prices:
Share options outstanding (thousands)For the financial year ended March 31
Grant dateExpiry dateExercise price (USD)202320222021
June 25, 2019June 23, 202710.59 461 461 487 
October 23, 2020August 15, 20268.50 1,540 2,443 2,589 
October 23, 2020August 15, 202610.50 1,304 2,068 2,192 
October 23, 2020August 15, 202612.50 1,067 1,692 1,793 
October 23, 2020August 15, 202614.50 830 1,316 1,396 
October 23, 2020August 15, 20266.42 894 — — 
October 23, 2020August 15, 20268.42 756 — — 
October 23, 2020August 15, 202610.42 619 — — 
October 23, 2020August 15, 202612.42 481 — — 
Total7,952 7,980 8,457 
Weighted average remaining contractual life of options outstanding at the end of the period3.4 years4.4 years5.4 years
Disclosure of Number and Reconciliation of Outstanding Restricted Shares
RSA MOD - Number of shares
RSA planVested at grant dateTo vest in the futureTotal
UnconditionalConditionalTotalUnconditionalConditionalTotal
RSA 2020 MOD13,379 — 13,379 13,380 13,378 26,758 40,137 
RSA 2021 MOD7,132 3,566 10,698 21,396 21,393 42,789 53,487 
RSAe 2021 MOD41,838 — 41,838 62,757 — 62,757 104,595 
Total62,349 3,566 65,915 97,533 34,771 132,304 198,219 
The following table shows the RSAs granted and outstanding at the beginning and end of the reporting period:
Number of shares (thousands)For the financial year ended March 31
202320222021
As of April 11,675 475 — 
Granted during the year962 1,426 475 
Vested during the year(539)(92)— 
Forfeited during the year(92)(134)— 
As of March 312,006 1,675 475 
Weighted average fair value (USD)5.18 6.628.65
Disclosure of Indirect Measurement of Fair Value of Restricted Shares Granted The model inputs were the share price at grant date and the risk free interest rate as stipulated in the table below. No dividend payments were considered in the fair value.
RSA 2020 NEDRSA 2020RSA 2020 MOD
Grant date23/10/202023/10/202023/10/202023/10/202023/10/202023/10/202023/10/202014/9/202214/9/2022
Vesting date5/3/20225/9/20225/9/20235/3/20225/9/20225/9/20235/9/20245/9/20235/9/2024
Share price at grant date (USD)8.64 8.64 8.64 8.64 8.64 8.64 8.64 4.83 4.83 
Risk free interest rate0.14 %0.17 %0.22 %0.14 %0.17 %0.23 %0.31 %4.21 %4.22 %
Fair value per share (USD)8.62 8.61 8.58 6.91 6.90 6.88 6.84 3.64 3.49 

RSA 2021RSA 2021 MODRSA 2021e
Grant date12/10/202112/10/202112/10/202112/10/202114/9/202214/9/202214/9/202214/9/202212/10/202112/10/2021
Vesting date5/9/20225/9/20235/9/20245/9/202514/9/20225/9/20235/9/20245/9/20255/9/20225/9/2023
Share price at grant date (USD)6.60 6.60 6.60 6.60 4.83 4.83 4.83 4.83 6.60 6.60 
Risk free interest rate0.10%0.21%0.40%0.62%0.10%0.21%0.40%0.62%0.10%0.21%
Fair value per share (USD)5.41 5.39 5.35 5.28 4.95 3.98 3.83 3.73 6.59 6.57 

RSA 2021e MODRSA 2022
Grant date14/9/202214/9/202214/9/202214/9/202214/9/202214/9/2022
Vesting date14/9/20225/9/202328/8/202328/8/202428/8/202528/8/2026
Share price at grant date (USD)4.83 4.83 4.83 4.83 4.83 4.83 
Risk free interest rate4.24%4.24%4.23%4.21%4.03%3.90%
Fair value per share (USD)6.59 4.63 3.70 3.55 3.42 3.30